INDEVUS PHARMACEUTICALS INC 4
4 · INDEVUS PHARMACEUTICALS INC · Filed Dec 8, 2008
Insider Transaction Report
Form 4
RITTER DALE
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2008-12-04+45,000→ 45,000 totalExercise: $3.56Exp: 2010-06-10→ Common Stock, $.001 par value per share (45,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2008-12-04−45,000→ 0 totalExercise: $3.56Exp: 2009-06-10→ Common Stock, $.001 par value per share (45,000 underlying)
Footnotes (3)
- [F1]All of the reported transactions involved the amendment of outstanding stock options to extend the respective expiration dates from 6/10/2009 to 6/10/2010; such extensions are considered by the Securities and Exchange Commission to be cancellations of the current stock options.
- [F2]Prior to the extension of the current stock option, such stock option was fully exercisable.
- [F3]This stock option is fully exercisable as of the date of this report.